Smart Sourcing in Pharma R&D
Innovation remains non-negotiable in pharmaceutical R&D – but so does cost discipline. With longer innovation cycles, tightening budgets, and increasingly complex supplier ecosystems, traditional ways of managing R&D expenses are no longer sustainable. Leading pharma companies are now proving that strategic sourcing can reduce costs, improve transparency, and accelerate innovation – without compromising patient safety or scientific rigor.
What can you take away from this article?
This article shows how procurement is evolving into a strategic partner for R&D, enabling companies to balance scientific ambition with financial discipline. You will learn:
- Why R&D sourcing must move from fragmented, informal practices to structured governance models.
- How supplier segmentation and long-term CRO partnerships improve cost transparency and performance.
- The role of early demand and scope management in avoiding redundant service layers and enabling competitive pricing.
- How consistent commercial frameworks – from milestone-based payments to incentive models – simplify contracts and boost accountability.
The article is part of our magazine issue Achieving Cost Excellence.
In addition, you will also receive the following articles when you download the issue:
When companies think about cost excellence, they often focus on direct categories – the inputs for their core products or services. But indirect spend, from IT and logistics to professional services and facilities, typically represents 20–30% of outgoings and remains heavily under-managed.
Cost+ contracts are gaining traction in the energy sector as a flexible solution for high-risk, high-stakes projects. But without the right governance, transparency, and collaboration, they can quickly spiral into inefficiency and overspend.
Innovation remains non-negotiable in pharmaceutical R&D – but so does cost discipline. With longer innovation cycles, tightening budgets, and increasingly complex supplier ecosystems, traditional ways of managing R&D expenses are no longer sustainable.
Inflation, shifting consumer expectations, and ongoing supply chain disruptions are reshaping the role of private label in food retail.
For decades, high-stakes negotiations were defined by gut instinct, personal persuasion, and last-minute deals. But a quiet revolution is underway: process driven negotiations are transforming procurement into a discipline built on structure, transparency, and incentives.
In this exclusive interview, our sector experts Matthew Rose (TMT) and José Carande Morgado (Banking) reveal how procurement is evolving from a cost enforcer to a true strategic partner in two of the world’s most dynamic sectors.
Achieving cost excellence is no longer optional; it’s a strategic necessity. In this expert interview, Stephan Kunigk, Chief Procurement Officer at Amprion, shares how Amprion restructured its procurement to drive efficiency, resilience, and long-term value in a rapidly evolving energy landscape.
Please complete the contact form to request the magazine. You will then receive the full issue by e-mail.
// Preview | Table of contents & editorial
Authors
Further Articles of our Magazine
Beyond the Price Tag
How Smart Procurement is Powering Big Energy Projects
The Rise of Process Driven Negotiations
When Rules Rule
From Cost Pressure to Strategic Advantage
How procurement is unlocking cost optimization in TMT and Banking